心脑血管病与他汀类药物的调脂与非调脂作用的临床研究
出处
《中国初级卫生保健》
2005年第3期93-94,共2页
Chinese Primary Health Care
参考文献14
-
1谭建聪,刘光耀,杨成玉,陈伟.高血压病人血脂与细胞膜离子转运的关系[J].第三军医大学学报,1997,19(4):359-361. 被引量:16
-
2陈君柱,张芙荣,朱建华,朱军慧,谢旭东,孙坚,尚云鹏,郭晓纲.他汀类药物对外周血内皮祖细胞数量和功能的影响[J].中华心血管病杂志,2004,32(4):346-350. 被引量:21
-
3吕以杰,颜淑红,郭涛,朱世明,苗伟,孙德成.辛伐他汀对不同血脂水平急性冠状动脉综合征患者血清基质金属蛋白酶水平的影响[J].中华心血管病杂志,2004,32(2):109-113. 被引量:27
-
4邓中龙,罗海明,符德玉,姚望,吴国佳,姚春梅.辛伐他汀对血压影响的临床观察[J].心血管康复医学杂志,2004,13(3):235-237. 被引量:1
-
5Vasa M, Fichtlscherer S, Adler k, et al. Increase in circulating endothelial progenitor cells by stain therapy in patients with stable coronary artery disease.Circulation,2001,103 : 2 885-2 890.
-
6Dimmeler S, Alcher A, Vasa M, et al. HMG-CoA-reductase inhibitors (stains) increase endothelial progenitor cells Via the P13 kinase/Akt pathway. J Clin Invest,2001, 108:391-397.
-
7Murohara T, Tepper O, Silver M, et al. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization. Exp Hematol, 2002, 30:967.
-
8Suzuki T, rqishida M, Futami S, et al. rqeoendothelialization after peripheral blood stem cell transplantation in humans.A case report of a Tokaimura nuclear accident victim.Cardiovasc Res, 2003,58:487-492.
-
9Kalka C, Masuda H, Takahashi T, et al.Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA, 2000, 97:3 422-3 427.
-
10Schatteman GC, Hanlon HP, Jiao C, et al. Blood-derived angioblasts accelerate bloodflow restoration in diabetic mice.J Clin Invest, 2000, 106:571-578.
二级参考文献32
-
1谭建聪,刘光耀.高血压病患者红细胞钠氢离子交换及钙离子内流的变化[J].中华医学杂志,1993,73(12):759-760. 被引量:5
-
2[2]The six report of the Joint National Committee on Prevention,detection, evaluation, and treatment of high blood pressure [J].Arch InternMed, 1997, 157 (21): 2413-2446.
-
3[5]Omboni S, Parati G, Zanchetti A, et al. Calculation of trough:peak ratio of antihypertensive treatment from ambulatory blood pressure : methodological aspects [J]. J Hypertens, 1995,13:1105.
-
4[6]Goode G, Miller J, Heagerty A. Hyperlipidemia, hypertension,and coronary heart disease [J]. Lancet, 1995, 345: 362.
-
5[9]Laufs U, La--Fats V, Plutzky J, et al. Up-regulation of endothelial nitric oxide synthase by HMG-COA reductase inhibitors [J]. Circulation. 1998, 97 (12): 1129-1135.
-
6[10]Brouet A, Sonveaux P, Dessy C, et al. Hspqo and coveolin are key targets for the proangiogenic hitric oxide mediated effects of statins [J]. Circulation Research, 2001, 89 (10): 866-873.
-
7丁振华,生理科学进展,1994年,25卷,12期,67页
-
8Asahara T, Murohara T, Sullivan A, et al. Isolation of putative endothelial progenitor cells for angiogenesis. Science, 1997, 275: 964-967.
-
9Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood, 2000, 95: 952-958.
-
10Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res, 1999, 85: 221-228.
共引文献61
-
1范彦夫,谭秋波,齐建祥.大剂量辛伐他汀治疗心绞痛合并高胆固醇血症的临床观察[J].黑龙江医药科学,2005,28(2):58-59.
-
2杨士芝,吴茂礼,孙培欣.普拉固消褪动脉粥样斑块的临床观察[J].基层医学论坛,2005,9(5):465-465.
-
3邓根群,李永旺,曲鹏.基质金属蛋白酶-9在急性冠状动脉综合征患者血清中的表达[J].中国医师杂志,2005,7(5):692-693.
-
4冯姗,李颢.两种剂量辛伐他汀治疗急性冠脉综合征的临床疗效评价[J].中国医院用药评价与分析,2005,5(3):146-148. 被引量:2
-
5谭燮文,阮劲,李力,黄康民.男性甘油三酯水平与高血压检出率的关系[J].中国慢性病预防与控制,2005,13(4):166-167. 被引量:1
-
6季亢挺,张怀勤,杨德业,黄小燕,黄伟剑,林捷,徐力辛.普伐他汀对内皮祖细胞培养中扩增及黏附能力的影响[J].温州医学院学报,2005,35(4):265-267. 被引量:1
-
7蒋作锋,韦建瑞,赵洪磊,谭宁.阿托伐他汀对不稳定型心绞痛患者高敏C反应蛋白的影响[J].岭南心血管病杂志,2005,11(4):262-264.
-
8刘屹.他汀类药物在动脉粥样硬化中的应用[J].临床医药实践,2005,14(9):647-649.
-
9王娟,赵虹.不同剂量辛伐他汀对急性冠状动脉综合征患者高敏C反应蛋白的影响[J].河北医药,2005,27(10):741-742. 被引量:4
-
10李志,张娟,丁国锋.急性冠状动脉综合征患者早期辛伐他汀干预对血脂和高敏C反应蛋白的影响[J].滨州医学院学报,2005,28(6):420-422. 被引量:3
-
1刘瑞婵.门诊抗高血压药物处方分析[J].中国基层医药,2008,15(3):479-479. 被引量:1
-
2刘时武,丁世芳.他汀类药物的非调脂作用[J].华南国防医学杂志,2008,22(2):63-65. 被引量:13
-
3吴苏舒,刘玉明,陈静.他汀类药物调脂外临床应用概况[J].药学实践杂志,2007,25(1):4-6. 被引量:8
-
4姜玲敏.微生物、机体、抗菌药三者间关系谈合理使用抗菌药[J].现代医药卫生,2002,18(2):160-162.
-
5王志文,尹富玲.维生素C降低胆固醇值[J].食品与健康,1996(5):5-5.
-
6张炜.色氨酸的致病性[J].前卫医学情报,1993,9(2):47-49.
-
7野野.阿司匹林耐受性与心血管病发病率和死亡率风险增加有关[J].中华医学信息导报,2002,17(14):9-9.
-
8杨胜利,刘惠亮,何作云.他汀类药物对血管及血栓形成的作用[J].心血管康复医学杂志,2005,14(6):589-592. 被引量:3
-
9孙会,王君库,唐天伟.氟伐他汀辅助治疗急性心肌梗死疗效观察[J].中国煤炭工业医学杂志,2008,11(11):1741-1741.
-
10王小京,文仪.补充维生物C可降低心脏病风险[J].国外医学情报,2004,25(6):40-40.